In addition, Figures 4B-O showed the KM survival curves of CCT4 expression in some cancers (at least three survival indicators had clinical significance), such as in BRCA, LUAD, and UCEC, high CCT4 expression was associated with a poor survival period (p < 0.05) (Figures 4B-L); but in LGG, high expression of CCT4 was associated with a better survival period (p < 0.05) (Figures 4M-O). The gene discussed is CCT4; the disease is cancer.